|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192976-04
|
$144,556
|
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
Distance Education to Engage Alaskan Community Health Aides in Cancer Control
|
5R25CA186882-04
|
$160,384
|
|
CUEVA, MELANY
|
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
5R44CA199667-02
|
$835,665
|
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
Couple Communication in Cancer: A Multi-Method Examination
|
5R01CA201179-02
|
$650,269
|
|
LANGER, SHELBY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
1R21CA217137-01
|
$209,093
|
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors
|
5R01CA194473-03
|
$347,361
|
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
MicroRNA Biomarkers for Determining Treatment Response in Colorectal Cancer
|
5R01CA202797-02
|
$352,363
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
|
5U01CA187956-04
|
$496,015
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
|
5UH2CA213385-02
|
$49,295
|
|
CHEN, WENYONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
5R01CA181045-04
|
$710,976
|
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Integration of Palliative Care for Cancer Patients on Phase I Trials
|
5R01CA177562-04
|
$1,356,827
|
|
FERRELL, BETTY
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Geriatric Oncology: Educating nurses to improve quality care
|
5R25CA183723-03
|
$272,197
|
|
HURRIA, ARTI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas
|
5R01CA198076-03
|
$1
|
|
PORTNOW, JANA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Quantitative Epigenetic Test for Guiding Smoking Cessation Therapy
|
5R44CA213507-02
|
$642,098
|
|
PHILIBERT, ROBERT
|
BEHAVIORAL DIAGNOSTICS, INC.
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-02
|
$474,276
|
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Uncoupling obesity from breast cancer in African American women
|
5U01CA182898-05
|
$650,118
|
|
DENIS, GERALD
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-06
|
$639,740
|
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
5P01CA066996-19
|
$2,248,452
|
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
When Outcomes Matter: A Temporal Analysis of Instrumental and Affective Outcomes of Exercise Behavior using Ecological Momentary Assessment
|
5F31CA206245-02
|
$44,044
|
|
EMERSON, JESSICA
|
BROWN UNIVERSITY
|
|
Nanosystems Biology Cancer Center
|
5U54CA199090-03
|
$2,403,338
|
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Clinical Oncology Research Career Development Program (CORP)
|
5K12CA076917-20
|
$733,989
|
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases
|
5R21CA209304-02
|
$206,843
|
|
GREENFIELD, EDWARD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Treatment of glioblastoma using chain-like nanoparticles
|
5U01CA198892-03
|
$617,516
|
|
KARATHANASIS, EFSTATHIOS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The Development of Novel Mechanistically-based APE/Ref-1 Redox Inhibitors
|
5K08CA179084-04
|
$113,074
|
|
YANG, SUN
|
CHAPMAN UNIVERSITY
|
|
1/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities
|
5P20CA202923-03
|
$76,675
|
|
KHAN, SOHAIL
|
CHEROKEE NATION
|
|
Early Phase Clinical Trials in Imaging and Image-Guided Interventions
|
5R01CA197137-03
|
$235,564
|
|
KIM, AERANG
|
CHILDREN'S RESEARCH INSTITUTE
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach(2 of 2)
|
5U54CA132378-10
|
$1,339,371
|
|
HUBBARD, KAREN
|
CITY COLLEGE OF NEW YORK
|
|
The TREND Partnership: Translational Research Education and Training to Eliminate Tobacco Disparities (1/2)
|
5P20CA192993-04
|
$167,238
|
|
SMITH, PHILIP
|
CITY COLLEGE OF NEW YORK
|
|
CryoPen: An Innovative Treatment for Cervical Precancer in Low-Resource Setting
|
5UH3CA189883-05
|
$936,421
|
|
CREMER, MIRIAM
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
|
5R01CA190092-04
|
$552,684
|
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
Methylation and mutations in RB1 and variants of synthetic folic acid metabolism
|
5R01CA192662-03
|
$1
|
|
ORJUELA, MANUELA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer
|
5F31CA192891-04
|
$49,044
|
|
PRICE, JESSICA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Genomics and Mechanisms of Esophageal Carcinogenesis
|
5R01CA208711-02
|
$366,000
|
|
SEPULVEDA, ANTONIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment
|
5R01CA185457-04
|
$640,378
|
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
A Phase I Dose-escalation Study of Intraperitoneal CYN101 as Consolidation Immunotherapy in Women with Residual or Recurrent Ovarian Cancer Status after Chemotherapy
|
5R44CA206606-02
|
$1,004,186
|
|
WINRAM, SCOTT
|
CYNVEC, LLC
|
|
Material Hardship as a Targetable Measure of Poverty in Pediatric Cancer
|
5K07CA211847-02
|
$133,475
|
|
BONA, KIRA
|
DANA-FARBER CANCER INST
|
|
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
|
5P01CA142106-13
|
$1,630,446
|
|
CUTLER, COREY
|
DANA-FARBER CANCER INST
|
|
Genetics of Prostate Cancer in Africa
|
5U01CA184374-03
|
$1,707,746
|
|
REBBECK, TIMOTHY
|
DANA-FARBER CANCER INST
|
|
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156732-07
|
$1,834,682
|
|
VISWANATH, KASISOMAYAJULA
|
DANA-FARBER CANCER INST
|
|
Comprehensive dissection of the CLL genome and phenome to improve patient outcomes
|
5P01CA206978-02
|
$1,755,838
|
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer
|
5R35CA210057-02
|
$1,007,233
|
|
ZHAO, JEAN
|
DANA-FARBER CANCER INST
|
|
Dissecting mechanism(s) by which ionizing radiation promotes clonal expansion of premalignant cells in the thymus
|
5K99CA212198-02
|
$116,127
|
|
LEE, CHANG LUNG
|
DUKE UNIVERSITY
|
|
Development of a Numerical Model for Microbubble Enhanced Treatment in HIFU Therapy
|
1R43CA213866-01A1
|
$149,819
|
|
HSIAO, CHAO-TSUNG
|
DYNAFLOW, INC.
|
|
Planning a Regional Center of Research Excellence in Non-communicable Diseases in India
|
5P20CA210298-02
|
$242,714
|
|
GOODMAN, MICHAEL
|
EMORY UNIVERSITY
|
|
Esophageal Cancer from Cells to Population: A Multiscale Approach
|
5U01CA182940-05
|
$617,479
|
|
LUEBECK, GEORG
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Pacific Northwest Prostate Cancer SPORE
|
5P50CA097186-15
|
$2,220,357
|
|
NELSON, PETER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Molecular pathological epidemiology of colorectal cancer
|
5U01CA137088-08
|
$2,523,163
|
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Impact of aging on progression and prevention of mammary preneoplasia and cancer
|
5UH2CA213388-02
|
$75,386
|
|
FURTH, PRISCILLA
|
GEORGETOWN UNIVERSITY
|
|
Integrating Evidence-Based Smoking Cessation Interventions into Lung Cancer Screening Programs: A Randomized Trial
|
5R01CA207228-02
|
$606,515
|
|
TAYLOR, KATHRYN
|
GEORGETOWN UNIVERSITY
|
|
SCH: Creating Interactive of Models Healthcare Journeys to Improve Patient-C
|
5R01CA195653-04
|
$234,427
|
|
MYNATT, ELIZABETH
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
Total relevant funding to Gallbladder for this search: $956,261
|